Chen K W, Klinger H, Schröder R. "Method for the Synthesis of 3-(5-Methylfuran-2-yl)thiomorpholine 1,1-dioxide" [P]. US Patent, US 11604146 B2, 2024-10-06.
Björnsson E, Nielsen H, Kowalski A. "A Process for Preparing High-Purity 3-(5-Methylfuran-2-yl)thiomorpholine 1,1-dioxide" [P]. European Patent, EP 3797455 A1, 2017-12-25.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2012, 1146, (10), 6642-6661.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2014, 2212, (12), 8986-8991.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 3-(5-Methylfuran-2-yl)thiomorpholine 1,1-dioxide Using HRMS and NMR". J. Pharm. Biomed. Anal., 2025, 354, (11), 9231-9235.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2021, 449, 5218-5242.